|
|
|
|
Paradigm
Shift
Viral
Evolution
Intervention
Monitoring
Vaccine
Screening
Vaccine
Development
Expression
Profiling
Drug
Discovery
Custom
Therapies
Patents
|
|
|
Audio: Jan28 Apr21 Sep22
Commentary
Fixing
H1N1
Tamiflu Resistance In the Philippines
Recombinomics Commentary
19:07
September 29, 2008
In South Africa, a total of
283 A(H1N1) viruses have been isolated during the 2008 influenza season
as of 9 September.
Of those, 129 isolates have
been tested for oseltamivir resistance by the National Institute of
Communicable Diseases (NICD) and 100% were found to be resistant to
oseltamivir by genotypic
analysis.
In Australia, 25 of 26,
Argentina, 11 of 25, Chile, 6 of 44 A(H1N1) viruses analysed showed the
specific neuraminidase mutation (H274Y) associated with oseltamivir
resistance, respectively.
WHO has also received
reports from NICs in other parts of the world; In the Russian
Federation, 9 of 20, and Philippines, 10 of 11 A(H1N1) viruses tested
were found to be resistant, respectively.
The above comments provide additional updates on Tamiflu resistance in
the southern hemisphere and indicate that resistance is at or near 100%
in South Africa (129/129), Australia (25/26), and the Philippines
(10/11).
The levels suggest the Tamiflu resistance is becoming fixed
in the above countries, and will likely become fixed in new versions of
clade 2B that emerge in the upcoming season, in spite of targeting
Brisbane/59 in the current vaccine for the northern hemisphere and the
upcoming vaccine for the southern hemisphere.
Media Links
Recombinomics Presentations
Recombinomics
Publications
Recombinomics
Paper
at Nature Precedings
|